US Stock Market Closed

Dashboard

Tilray, Inc. (TLRY)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

B

Management & Equity

B

Analyst Opinion

B

Leverage & Liquidity

B

Fundamental Variables

H

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

CEO

Brendan Kennedy

Employees

1,646

Industry

Crop Production

Sector

Consumer Staples

Headquarters

Nanaimo

Exchange

NASDAQ

Summary Stats

Market Cap

1.78B

Revenue

523M

Net Income

-340M

EPS

-$1.36

Price-to-Earnings

-2.63

Price-to-Book

0.39

Debt-to-Equity

0.26

News

Analyst Ratings

Price targets projected by 13 analysts

High

$15.00

Average

$9.06

Low

$4.00

Ratings calculated by 17 analysts

Buy

2

Hold

13

Sell

2

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q3 2022

Last Earnings

Not Available

Actual

$0.03 -

Consensus

-

Report Date

Year Ago

-

Year Ago Change %

-

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites